Study on the Immunogenicity and Safety of Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) After Inoculation With Two Doses of Inactivated Vaccine (CoronaVac) in People Over 18 Years Old
Latest Information Update: 20 Sep 2023
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; ZF 2001 (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Sponsors Anhui Zhifei Longcom Biopharmaceutical
Most Recent Events
- 15 Sep 2023 Status changed from active, no longer recruiting to completed.
- 31 Jan 2022 New trial record